Biolistic Particle Delivery System Market Outlook:
Biolistic Particle Delivery System Market size was valued at USD 24.73 billion in 2025 and is expected to reach USD 77.5 billion by 2035, expanding at around 12.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of biolistic particle delivery system is evaluated at USD 27.42 billion.
The integration of artificial intelligence (AI) is one of the main growth drivers fueling the market. AI integration in Biolistic Particle Delivery Systems can enhance the entire process, from experimental design to execution. AI algorithms can analyze vast datasets, predict optimal parameters for particle delivery, and adapt in real-time to the specific requirements of diverse cell types. This intelligent automation can significantly reduce the time and resources traditionally required for system optimization and experimental setup. A study published demonstrated a 20% improvement in gene delivery efficiency when AI algorithms were employed to optimize particle velocity and penetration depth in a Biolistic system.
Biolistic particle delivery systems, also known as gene guns, are devices used in genetic engineering and biotechnology to introduce foreign genes into target cells. They are commonly used in plant transformation and have applications in genetic research and biopharmaceutical development. Supportive regulatory environments that facilitate the development and commercialization of genetic engineering technologies can positively impact the growth of the market.
